Single-crystal – oriented-crystal – and epitaxy growth processes; – Processes of growth from liquid or supercritical state – Having growth from a solution comprising a solvent which is...
Reexamination Certificate
2007-06-19
2007-06-19
Kunemund, Robert (Department: 1722)
Single-crystal, oriented-crystal, and epitaxy growth processes;
Processes of growth from liquid or supercritical state
Having growth from a solution comprising a solvent which is...
C117S069000, C117S070000, C117S924000, C117S926000
Reexamination Certificate
active
10815339
ABSTRACT:
Provided is a method for crystallization and purification of a macrolide such as tacrolimus, sirolimus, pimecrolimus, or everolimus that includes the step of providing a combination of a macrolide, and a polar solvent, dopolar aprotic solvent, or hydrocarbon solvent at pH of 7 or above.
REFERENCES:
patent: 3993749 (1976-11-01), Sehgal et al.
patent: 4160861 (1979-07-01), Cole et al.
patent: 4543334 (1985-09-01), Celmer et al.
patent: 4894366 (1990-01-01), Okuhara et al.
patent: 5091389 (1992-02-01), Ondeyka et al.
patent: 5116756 (1992-05-01), Dumont et al.
patent: 5200505 (1993-04-01), Takesako et al.
patent: 5496727 (1996-03-01), Okuhara et al.
patent: 5506233 (1996-04-01), Hauske et al.
patent: 5508398 (1996-04-01), Gletsos
patent: 5622866 (1997-04-01), Motamedi et al.
patent: 5624842 (1997-04-01), Okuhara et al.
patent: 6387258 (2002-05-01), Keri et al.
patent: 2002/0128470 (2002-09-01), Fuenfschilling et al.
patent: 2003/0166924 (2003-09-01), Keri et al.
patent: 2004/0050782 (2004-03-01), Fuenfschilling et al.
patent: 2004/0266703 (2004-12-01), Keri et al.
patent: 692 839 (2002-11-01), None
patent: 2121517 (1972-11-01), None
patent: 0 184 162 (1986-06-01), None
patent: 0 652 219 (1995-05-01), None
patent: 1 234 833 (2002-08-01), None
patent: WO 92/18506 (1992-10-01), None
patent: WO 00/33878 (2000-06-01), None
Patent Abstract of Japan Publication No. 02016662; Publication date Jan. 19, 1990; Akashi Kazuya “Substituting Terminal Controller”.
Surjit S. Sengha, Fermentation, in Kirk Othmer Encyclopedia of Chemical Technology, vol. 10, p. 361-381 (Jacquiline I. Kroschwitz, editor, 4th ed. 1993).
The Merck Index, Maryadele J. O'Neil et al. eds., “Pirnecrolimus”, p. 1331, 13th ed. 2001.
Martindale: The complete drug reference, Sean C. Sweetman ed., “Sirolimus”, p. 568, Pharmaceutical Press 33rd ed. 2002.
C.E.M. Griffiths “Ascomycin: An Advance in the Management of Atopic Dermatitis” British J. of Dermatology, V. 144, p. 679-681, (2001).
Martindale: The compete drug reference, Sean C. Sweetman ed., “Everolimus”, p. 539, Pharmaceutical Press 33rd ed. 2002.
Zhiguo Song et al. “Highly Chemoselective Trichloracetimidate-Mediated Alkylation of Ascomycin: A Convergent, Practical Synthesis of the Immunosuppressant L-733,725” J. Org. Chem. 1999, v. 64, p. 1859-1867.
Jun'ichi Kobayashi et al. “Amphidinolides T2, T3, and T4, New 19-Membered Macrolides from theDinoflagellate amphidiniumsp. and the Biosynthesis of Amphidinolide T1” J. Org. Chem. 2001, v. 66, p. 134-142.
K. Yoshii et al. “Liquid Chromatographic Determination of Emamectin, Milbemectin, Invermectin and Abamectin in Crops and Confirmation by Liquid Chromatography—Mass Spectrometry” Journal of Chromatography A, v. 896, 2000, p. 75-85.
Csorvasi Andrea
Keri Vilmos
Kenyon & Kenyon LLP
Kunemund Robert
TEVA Gyógyszergyár Zártkörűen Mű
LandOfFree
Crystallization and purification of macrolides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Crystallization and purification of macrolides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystallization and purification of macrolides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3870149